USD $4305.61
Products matching the full generic name: Dasatinib
SPRYCEL is a prescription medication used to treat certain types of leukemia, specifically Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It belongs to a class of drugs known as tyrosine kinase inhibitors.
SPRYCEL works by inhibiting the activity of specific proteins that promote the growth of cancer cells. By targeting these proteins, SPRYCEL helps to stop the proliferation of cancer cells, thereby managing the progression of leukemia.
SPRYCEL is primarily prescribed for patients diagnosed with Ph+ CML or Ph+ ALL. It is often recommended for patients who have not responded well to other treatments or who have experienced side effects from other medications.
SPRYCEL is taken orally in tablet form. It is important for patients to follow their healthcare provider's instructions regarding dosage and administration to ensure optimal effectiveness.
Common side effects of SPRYCEL may include fatigue, nausea, diarrhea, and headache. Some patients may experience more severe side effects, and it is crucial to consult a healthcare provider immediately if unusual symptoms occur.
Patients should discuss their full medical history with their doctor before starting SPRYCEL. It is important to inform the healthcare provider of any existing health conditions and any other medications being taken to avoid potential interactions.
SPRYCEL is not recommended for use during pregnancy due to potential risks to the unborn child. Women of childbearing age should discuss contraceptive options with their healthcare provider while undergoing treatment with SPRYCEL.
For more detailed information about SPRYCEL, including clinical studies and patient support resources, please consult your healthcare provider or visit the official SPRYCEL website.
Health Guides